According to our latest research, the global bird flu treatment market size stood at USD 1.54 billion in 2024, reflecting the growing urgency for effective therapeutic interventions amid recurring avian influenza outbreaks worldwide. The market is projected to expand at a CAGR of 7.2% during the forecast period, reaching a value of approximately USD 2.88 billion by 2033. This robust growth is primarily driven by the increasing prevalence of bird flu, rising investments in research and development of antivirals and vaccines, and heightened awareness among healthcare providers and the general public about the potential risks associated with avian influenza.
https://growthmarketreports.co....m/report/bird-flu-tr